December 20, 2022
Steven J. Czinn, MD, the Drs. Rouben and Violet Jiji Endowed Professor and Chair of Pediatrics at the University of Maryland School of Medicine, announced today that Thomas K. Chin, MD, has been appointed to serve as the new Division Head of Pediatric Cardiology in UMSOM’s Department of Pediatrics, and as Co-Director of the Children’s Heart Program at the University of Maryland Children’s Hospital (UMCH), effective January 2023.
“We are very excited to have been able to recruit Dr. Thomas Chin. Tom has a long track record of working with physicians and surgeons to create nationally recognized Children’s Heart and pediatric cardiology programs that provide outstanding care,” said Dr. Czinn. “He is also an excellent educator who will initiate a pediatric cardiology fellowship program to stimulate both teaching and research.”
Dr. Chin joins Dr. Joseph Forbess, MD, MBA, Professor of Surgery, as Co-Director of the Children’s Heart Program. “We are very excited to have Dr. Chin joining us in the Children’s Heart Program,” said Dr. Forbess. “He will play a valuable role in the further growth and success of the Program.”
UMCH was named a “Best Children’s Hospital” for Pediatric Cardiology & Heart Surgery by U.S. News & World Report in 2022 for the fifth year in a row. UMCH's Children's Heart Program itself is renowned for achieving outcomes that regularly exceed national standards in overall case survival, survival by complexity category, and length of stay. The program provides comprehensive cardiac care for children, from fetal life into adulthood, with congenital heart disease, and for children with acquired heart disease.
“I am excited to be joining the excellent team of cardiologists and surgeons at the Children’s Heart Program at the University of Maryland School of Medicine,” said Dr. Chin. “I believe the program is poised to lead the nation in patient care, research, and the training of the next generation of physicians—and I hope to be a part of the success of the program.”
Dr. Chin currently is a Professor of Pediatric Cardiology at Penn State College of Medicine, where he served as the Chief of Pediatric Cardiology for nine years. He is also the co-director of the perinatal program and former director of the pediatric cardiology fellowship program at the nationally ranked Penn State Health Children's Hospital’s Children’s Heart Group, with a focus on pediatric and congenital heart surgery outcomes. Previously, he served as chief of pediatric cardiology at East Tennessee State University College of Medicine in Johnson City, TN, then served as chief of pediatric cardiology and co-chair of the Pediatric Heart Institute at LeBonheur Children’s Hospital at the University of Tennessee College of Medicine, as well as chief of pediatric cardiology at St. Jude Children's Research Hospital in Memphis, TN.
He has published 106 peer-reviewed scientific papers, abstracts, and book chapters, most recently as the co-author of the article, Use of AliveCor Kardia Mobile in the Detection of Supraventricular Tachycardia in a Pediatric Population, published in Congenital Cardiology Today, October 2021. He has also engaged in research activities, including the prediction of clinical outcome in patients with Left Ventricular noncompaction cardiomyopathy, and was a Site Investigator in a leading multi-center, phase I and II trials in a dose study of Tadalafil to assess the pharmacokinetics and safety in a pediatric population with pulmonary arterial hypertension sponsored by Eli Lilly. As a researcher in the laboratory, he measured electrical currents, calcium signals and contractions in individual heart cells from immature hearts, and worked with a number of collaborators including the intramural section of the NIH.
Dr. Chin is a fellow of the American College of Cardiology and the American Academy of Pediatrics. He recently served as president of the Capital Region American Heart Association and reviews abstracts and grants for the national American Heart Association. Castle Connolly Top Doctors has named him a Top Doctor in Pediatric Cardiology nine times in the past ten years.
Contact
Office of Public Affairs
655 West Baltimore Street
Bressler Research Building 14-002
Baltimore, Maryland 21201-1559
Contact Media Relations
(410) 706-5260
Related stories
Monday, November 21, 2022
UM School of Medicine Empowers Faculty Members Through Recently Founded Academy for Career Development
Within a year of the launch of the Medical Education Leadership Academy (MELA) at the University of Maryland School of Medicine (UMSOM), faculty members from across the School’s various divisions are expressing an overwhelmingly positive response to the Academy’s mission of creating an environment that fosters career development of a diverse community of nationally recognized leaders in medical education.
Tuesday, August 30, 2022
$800K Donation Will Fund New Discoveries and Treatments for ALS
The University of Maryland School of Medicine (UMSOM) will receive an $800,000 donation to be used by the University of Maryland Brain and Tissue Bank to advance research into the treatment and cure of Amyotrophic Lateral Sclerosis (ALS), commonly referred to as Lou Gehrig’s Disease.
Friday, December 18, 2020
Low-Income Preschoolers Exposed to Nurturing Care Have Higher IQ Scores During Their Teen Years, Landmark Study Finds
Preschoolers living in impoverished communities who have access to a nurturing home environment have significantly higher intelligence quotient (IQ) scores in adolescence compared to those raised without nurturing care. That is the finding of a new international study conducted by University of Maryland School of Medicine (UMSOM) researchers, which examined data from more than 1,600 children who were followed from birth through their teenage years. Results were published this week in The Lancet Child & Adolescent Health journal.
Monday, June 17, 2019
Primate Study Finds New Evidence that Growth Factor Plays Key Role in Maintaining Healthy Pregnancy
About 1 in 10 pregnant women experience placenta abnormalities that lead to life-threatening preeclampsia (hypertension), preterm labor and fetal growth problems, but finding effective treatments to effectively prevent or reverse these conditions has so far been elusive. A new research finding from University of Maryland School of Medicine (UMSOM) researchers, published in the June issue of the journal Endocrinology, could have important implications for developing novel treatments to prevent placental abnormalities.
Monday, September 11, 2017
Research Identifies Causes and Possible Treatments for Deadly Diseases Affecting Children in Developing Countries
University of Maryland School of Medicine Researchers Explore How to Prevent Diarrheal Diseases, a Leading Cause of Death in Young Children in Sub-Saharan Africa and South Asia
Wednesday, March 15, 2017
New Director Appointed to Lead the University of Maryland Children's Hospital
University of Maryland Medical Center (UMMC) President and Chief Executive Officer Mohan Suntha, MD, MBA and University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA, announced today that Steven J. Czinn, MD, The Drs. Rouben and Violet Jiji Endowed Professor of Pediatrics and Chair of the Department of Pediatrics at the University of Maryland School of Medicine, has been appointed to the role of Director of the University of Maryland Children’s Hospital (UMCH).